Reply to "CRISPR screens are feasible in TP53 wild-type cells".
Published version
Repository URI
Repository DOI
Change log
Authors
Haapaniemi, Emma
Persson, Jenna
Abstract
Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups.
Description
Keywords
CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats, DNA Damage, Gene Editing, Tumor Suppressor Protein p53
Journal Title
Mol Syst Biol
Conference Name
Journal ISSN
1744-4292
1744-4292
1744-4292
Volume Title
15
Publisher
EMBO
